98.66 %HemotypeSC® had a negative predictive value (NPV) of 98.66% (95% CI: 98.24–99.03) to detect sickle cell disease carrier status.
MalidrépanocytoseHAL · Unilimdocument of 103 observations
Gold tier: mechanically validated evidence, with its primary source.
1,197 evidence items · page 5 / 48
98.66 %HemotypeSC® had a negative predictive value (NPV) of 98.66% (95% CI: 98.24–99.03) to detect sickle cell disease carrier status.
MalidrépanocytoseHAL · Unilimdocument of 103 observations
1,561 casesOver the whole period, 1,561 malaria cases were treated by mobile health teams.
MalipaludismeHAL · Unilimdocument of 80 observations
364 daysIn a cohort study in Bandiagara, Mali, from June 2009 to June 2010, hemoglobin AC and AS children had a median of 364 malaria-free days before first clinical malaria episode.
Malipaludismeobserved June 2009 to June 2010published 2015The Journal of infectious diseaseseurope_pmcdocument of 10 observationsDOI 10.1093/infdis/jiv308
The malaria incidence was highest among children under five in Kidal, Mali during the 2024 epidemic.
MalipaludismeHAL · Unilimdocument of 80 observations
80 %80.0% of HIV samples from Mali were identified as HIV-1 subtype A.
MaliHIV-1 subtype Apublished 1998PubMedOpenAlexdocument of 10 observations
0.74 %Dans le groupe de dépistage actif, la prévalence des gamétocytes de Plasmodium falciparum était de 0,74 % chez les enfants âgés de 5 à 9 ans.
MalipaludismeHAL · Unilimdocument of 214 observations
0.45 odds_ratioThe risk of anemia was lower during the first trimester of gestational age, with an odds ratio of 0.45.
Malianémieobserved 1993published 2003Acta tropicaeurope_pmcdocument of 8 observations
27 %Zanthoxylum zanthoxyloides était utilisé contre les maux de dents avec une fréquence de citation de 27 %.
Malimaux de dentsHAL · Unilimdocument of 20 observations
1,480 décèsEn 2020, les formations sanitaires du Mali ont enregistré 1480 décès liés au paludisme.
Malipaludismeobserved 2020HAL · Unilimdocument of 214 observations
39 %In Mali, seasonal malaria chemoprevention reduced malaria illness incidence by 39% with an incidence rate ratio of 0.61 and 95% confidence interval 0.44–0.84.
MalipaludismeHAL · Unilimdocument of 110 observations
30 %Plasmodium vivax infections were detected in close to 30% of the cases among febrile patients recruited in five cities in Northern Mali.
Malipaludismepublished 2012Malaria journaleurope_pmc
3.3 timesThe risk of moderate headache was 3.3 times as high with 40 mg of CIS43LS per kilogram as with placebo.
Maliheadachepublished 2022The New England journal of medicineeurope_pmcdocument of 5 observations
0.26 proportionThe minor allele frequency of the E670G polymorphism in the study population sample was 0.26.
Malipaludismepublished 2018PloS oneeurope_pmcdocument of 6 observationsDOI 10.1371/journal.pone.0192850
95.22 %HemotypeSC® had a sensitivity of 95.22% [95% CI: 93.74–96.70] for diagnosing possible sickle cell disease (SCD) compared to high-performance liquid chromatography in a study in Mali, April–August 2021.
Malidrépanocytoseobserved April–August 2021HAL · Unilimdocument of 103 observations
1.48 per_1000_person_weeksFrom May 2024 to February 2025, children aged 0–11 months had 1.48 severe malaria cases per 1,000 person-weeks in the Kidal region.
Malipaludismeobserved 2024-2025HAL · Unilimdocument of 80 observations
La prévalence du paludisme a progressivement diminué au fil des ans dans une zone rurale du Mali.
MalipaludismeHAL · Unilimdocument of 214 observations
10 parasites/μlLa goutte épaisse peut détecter les parasites à un seuil inférieur à 10 parasites/μl de sang.
MalipaludismeHAL · Unilimdocument of 214 observations
20 %The seroprevalence of SARS-CoV-2 in the neighborhoods of the urban commune of Tombouctou varied from 20% to 47%.
MaliCOVID-19HAL · Unilimdocument of 88 observations
2,583 individualsThe study included 2583 SCD patients and healthy controls aged 5–21 years old in Mali, Senegal, Cameroon, Gabon and the Ivory Coast.
Cameroun · Côte d'Ivoire · Gabon · Mali · Sénégaldrépanocytosepublished 2019British journal of haematologyeurope_pmcdocument of 6 observations
0.22 %The prevalence of HbCC among 3648 newborns in Mali was 0.22%.
MaliHbCCobserved April–August 2021HAL · Unilimdocument of 103 observations
27 %Over a 16-month period, 82 (27%) children experienced at least one asymptomatic Plasmodium parasitæmia episode.
MaliPlasmodium parasitæmiaobserved 16-month periodpublished 2021Gut Microbiota Influences Plasmodium Falciparum Malaria Susceptibilityeurope_pmcdocument of 2 observationsDOI 10.20944/preprints202105.0710.v1
63.9 %63.9% of mothers did not know the complications of sickle cell disease.
Malidrépanocytosepublished 2009Мир науки, культуры, образованияOpenAlexdocument of 12 observations
16 %In children who received RTS,S/AS01E vaccine in Burkina Faso and Mali, 16% showed a 10-fold increase in anti-CSP IgG antibody titres post-2019 as measured by Oxford MSD assay.
Burkina Faso · Malipaludismeobserved post-2019HAL · Unilimdocument of 105 observations
1,960 parasites/microlitreLa médiane du nombre de parasites de Plasmodium malariae par microlitre chez les 95 patients du groupe Kollé est de 1 960 (IQR : 1 130–2 100).
MalipaludismeHAL · Unilimdocument of 62 observations
21 %In Mali, 21–71% of cases classified as early treatment failure had sensitive or RI parasitologic responses to chloroquine treatment for uncomplicated P. falciparum malaria.
Malipaludismepublished 2001The American journal of tropical medicine and hygieneeurope_pmcdocument of 3 observationsDOI 10.4269/ajtmh.2001.64.242
Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.